Metabolic-associated fatty liver disease (MASLD) impacts roughly 30% of people globally and has long lacked effective, targeted therapies. Now, researchers
stay healthy…
Metabolic-associated fatty liver disease (MASLD) impacts roughly 30% of people globally and has long lacked effective, targeted therapies. Now, researchers